About The Society for Brain Mapping and Therapeutics (SBMT)

The Society for Brain Mapping and Therapeutics (SBMT) is a non-profit society organized for the purpose of encouraging basic and clinical scientists who are interested in areas of Brain Mapping, engineering, stem cell, nanotechnology, imaging and medical device to improve the diagnosis, treatment and rehabilitation of patients afflicted with neurological disorders.

This society promotes the public welfare and improves patient care through the translation of new technologies/therapies into life saving diagnostic and therapeutic procedures. The society is committed to excellence in education, and scientific discovery. The society achieves its mission through multi-disciplinary collaborations with government agencies, patient advocacy groups, educational institutes and industry as well as philanthropic organization.

Educational Objectives

Upon completion of the scientific meeting, participants should be able to:

  • Identify new findings in brain mapping (BM) & intraoperative surgical planning (ISP) most relevant to their own sub field (i.e. molecular imaging and or biophotonics);
  • Describe the effect of the newly developed methods in medical imaging, medical devices, nanotechnology, stem cell/cellular therapy;
  • Discuss and design the possible future research and developments in BM, ISP and Nano-Bio-Electronics and assess the possible impact of such research and development on their own clini-cal and scientific work in the future;
  • Describe and assess the latest cutting-edge technological advancement in BM & ISP such as emerging field of nano-bio-electronics (integration of nanotechnology with stem cell/cellular ther-apy, medical imaging and medical devices);
  • Explain ways to build a bridge amongst multiple disciplines;
  • Educate the audience about the advancements in other disciplines and explain how such advancements could help them formulate new diagnostics and treatment modalities;
  • Discuss and describe governmental agencies, foundations, and industry roles in research and development of the field.

Specific Program


  • Scientific Exhibits (posters)
  • Special focus sessions
  • Basic science
  • Clinical trials
  • Governmental regulation (i.e. grant writing sessions)
  • Patient family
  • Cutting edge research and development in BM and ISP

Topics for Scientific Papers

  • SBMT annual meeting organizers encourage cross-disciplinary topics such as:
  • General issues
  • Operational issues
  • Image guided systems
  • Vascular & Blood flow imaging
  • ISP & Image guided surgery (OR of the future)
  • BM and ISP in Stereotactic Radiosurgery (proton Therapy, Novalis, Tomo-therapy, Varian system, Xknife, gamma knife and cyberknife technologies will be compared and contrasted)
  • Molecular and cellular imaging including: the use of nano-particles for stem cell and T-cell imaging
  • Anatomy
  • Nanoscience, genomics, computational informatics genetics in brain mapping
  • 4D, Neuro-mathematics and bio-informatics
  • Neurophysiology (EEG, MEG,...)
  • Functional brain mapping (fMRI, PET...)
  • Brain Mapping and Intra-operative Surgical Planning using Endoscopy
  • Biophotonics
  • Neural Prosthesis & Robotics (Human Brain machine Interface technology)
  • Multi-modality imaging and ultrasound
  • Perfusion imaging, micromagnetic resonance imaging
  • Magnetic resonance Spectroscopic Imaging
  • High-field and low-field magnetic resonance
  • Ethical issues related to the brain mapping and intra-operative surgical planning, Magneto encephalographic
  • Transcranial Magnetic Stimulation
  • Diffusion Tensor Imaging
  • SPECT functional Brain Mapping and histopathology in brain mapping
  • Healthcare Policy, Ethics and Regulatory affairs
  • Psychiatry (PTSD,...)
  • Imaging modalities for detecting mild/mod TBI, micro-TBI
  • Brain mapping/functional imaging for rehab medicine and PTSD
  • Minimally invasive therapy for TBI
  • Multimodality imaging for TBI and PTSD (DTI technology,…)
  • Rehabilitation Medicine (neural repair and regeneration for TBI,... Patients)

SBMT Charter

The Society for Brain Mapping and Therapeutics (SBMT) was founded in 2004 to break boundaries in healthcare. The society promotes policies that support rapid, safe, and cost-effective translation of new technology into medicine.

The SBMT globally promotes interdisciplinary research to improve the diagnosis, treatment, and rehabilitation of patients with central nervous system diseases regardless of race, creed, color, national origin, gender, or age.

The SBMT catalyzes interactions between clinical, biological, physical and engineering sciences. The Society builds transdisciplinary and translational consortia which break down traditional barriers that impede application of new technology to medical problems.

Translational research applies cutting edge basic science and advanced technologies to clinical neurosciences. The Society examines emerging disciplines such as nanotechnology, image-guided therapy, stem cell therapy, multi-modality imaging, biophotonics, and biomaterial and tissue engineering for their application to the diagnosis, treatment, and rehabilitation from neurological diseases. The Society seeks to apply these technologies to clinical problems such as brain tumors, stroke, epilepsy, neurodegenerative diseases (Parkinson, Alzheimer, multiple sclerosis and ALS), traumatic brain and spinal cord injuries, autism, post traumatic stress disorder and other psychiatric illnesses.

The Society achieves its goals through meetings, fellowships, publications, international collaborations, consortiums, and policy forums. The SBMT is a nonprofit society which has obtained support from many government agencies (USA, EU and Asia), foundations, and multi-national corporations. The Society maintains its headquarters in West Hollywood, California.